Metraipolis › archive › dc_0396cd95b6f9

Recommendations for selection, treatment, and follow-up in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors: a Delphi consensus from the… — Europe PMC PMID:41806239

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41806239
DOI
10.1007/s12094-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-04T21:44:09.600Z
SHA-256 of the archived text
65d76ad231bccf295820db6d153d1d5ec25b5152efa35b35dfed9cf20d0e81d5
Stable URL of this page
https://metraipolis.com/documento/dc_0396cd95b6f9

How to cite

Recommendations for selection, treatment, and follow-up in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors: a Delphi consensus from the… — Europe PMC PMID:41806239 — Europe PMC (en), https://europepmc.org/article/MED/41806239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0396cd95b6f9 (Metraipolis archive dc_0396cd95b6f9, sha256 65d76ad231bccf295820db6d153d1d5ec25b5152efa35b35dfed9cf20d0e81d5)
BibTeX
@misc{dc0396cd95b6f9,
  title = {Recommendations for selection, treatment, and follow-up in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors: a Delphi consensus from the… — Europe PMC PMID:41806239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41806239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0396cd95b6f9; sha256 65d76ad231bccf295820db6d153d1d5ec25b5152efa35b35dfed9cf20d0e81d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41806239. Agents can read the archived copy with the MCP tool read_document.